Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Supply of Medicine and Medical / Surgical equipments : Phenotyping solid-phase immunoassay for anti-\nHLA Class I antibody screening {Analyte-\nspecific Reagent (ASR)}compatible with\nLuminex xMAP microbead technology-based\nFLEXMAP-3D compact flow cytometry platform,\ntogether with comprehensive accessories (if\napplicable), software, technical assistance,\ncapacity building & application support. [refer\nto special order conditions for prioritizing\nand/or selecting primary /predominant\nworkflow; solution offering objective & best\nquality evidence for clinical /technical impact\nand/or effect of assay gamut, sensitivity,\nspecificity, comparative variability, best\ndemonstrating native reactivity, lowest\ninterference, best quality control parameters,\nparticularly when compared to superior\n/comparative technologies together with most\nintuitive /capable software & best technical\nsupport solution to be selected as the\npredominant /primary solution]\nPacking : 25 Reaction etc .

STATE PHARMACEUTICALS CORPORATION OF SRI LANKA Sri Lanka has Released a tender for Supply of Medicine and Medical / Surgical equipments : Phenotyping solid-phase immunoassay for anti-\nHLA Class I antibody screening {Analyte-\nspecific Reagent (ASR)}compatible with\nLuminex xMAP microbead technology-based\nFLEXMAP-3D compact flow cytometry platform,\ntogether with comprehensive accessories (if\napplicable), software, technical assistance,\ncapacity building & application support. [refer\nto special order conditions for prioritizing\nand/or selecting primary /predominant\nworkflow; solution offering objective & best\nquality evidence for clinical /technical impact\nand/or effect of assay gamut, sensitivity,\nspecificity, comparative variability, best\ndemonstrating native reactivity, lowest\ninterference, best quality control parameters,\nparticularly when compared to superior\n/comparative technologies together with most\nintuitive /capable software & best technical\nsupport solution to be selected as the\npredominant /primary solution]\nPacking : 25 Reaction etc . in Pharmaceuticals. The tender was released on Dec 16, 2024.

Country - Sri Lanka

Summary - Supply of Medicine and Medical / Surgical equipments : Phenotyping solid-phase immunoassay for anti-\nHLA Class I antibody screening {Analyte-\nspecific Reagent (ASR)}compatible with\nLuminex xMAP microbead technology-based\nFLEXMAP-3D compact flow cytometry platform,\ntogether with comprehensive accessories (if\napplicable), software, technical assistance,\ncapacity building & application support. [refer\nto special order conditions for prioritizing\nand/or selecting primary /predominant\nworkflow; solution offering objective & best\nquality evidence for clinical /technical impact\nand/or effect of assay gamut, sensitivity,\nspecificity, comparative variability, best\ndemonstrating native reactivity, lowest\ninterference, best quality control parameters,\nparticularly when compared to superior\n/comparative technologies together with most\nintuitive /capable software & best technical\nsupport solution to be selected as the\npredominant /primary solution]\nPacking : 25 Reaction etc .

Deadline - Jan 27, 2025

GT reference number - 99883793

Product classification - Pharmaceutical products

Organization Details:

  Address - Sri Lanka

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 99883793

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Supply of Medicine and Medical / Surgical equipments : Phenotyping solid-phase immunoassay for anti-\nHLA Class I antibody screening {Analyte-\nspecific Reagent (ASR)}compatible with\nLuminex xMAP microbead technology-based\nFLEXMAP-3D c ompact flow cytometry platform,\ntogether with comprehensive accessories (if\napplicable), software, technical assistance,\ncapacity building & application support. [refer\nto special order conditions for prioritizing\nand/or selecting primary /predominant\nworkflow; solution offering objective & best\nquality evidence for clinical /technical impact\nand/or effect of assay gamut, sensitivity,\nspecificity, comparative variability, best\ndemonstra

Gt Ref Id - 99883793

Deadline - Jan 27, 2025

Share share

Similar Tenders :

Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database